Nisa Investment Advisors’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
OFM
LCM
DFO
Nisa Investment Advisors's NUVB Position: Q2 2026 in Review
Nisa Investment Advisors increased its Nuvation Bio (NUVB) stake by 33% in Q2 2026, buying an estimated $4.01K and bringing the position to 3,300 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2247.
Nisa Investment Advisors first reported a position in NUVB in Q1 2022 and has held it in 16 quarters since. The position peaked at $46.8K in Q2 2023. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.
- Nisa Investment Advisors held 3,300 shares of Nuvation Bio worth $18.7K as of Q2 2026.
- Nisa Investment Advisors bought 821 Nuvation Bio shares in Q2 2026, an estimated $4.01K.
- Nuvation Bio made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2247 holding.
- Nisa Investment Advisors first reported a position in Nuvation Bio in Q1 2022 and has held it in 16 quarters since.
- Nisa Investment Advisors's Nuvation Bio position peaked at $46.8K in Q2 2023.
- 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.
Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.